Skip to main content
UniHealth

Doctor search

Kristen Kay Steenerson, MD

Neurology · Stanford

NPI 1750646857

Medicare standing
Clear
Enrolled, allowed to bill and order, not excluded
Plans that list them
5
2 carriers
Offices
3

Offices

3 locations · Stanford Health Care · 3,152 clinicians in this group

Looking this up.

Hospitals listed: Stanford Health Care · Stanford Health Care Tri-Valley. That is not proof they admit you there this week.

Plans that list them

5 plans · 2 carriers

A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Steenerson’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.

5 of 5 plans

Plans whose provider directory lists this clinician
SCAN Balance (HMO C-SNP)SCAN Health PlanListedOct 3, 2026
SCAN Classic (HMO)SCAN Health PlanListedOct 3, 2026
SCAN MyChoice (HMO)SCAN Health PlanListedOct 3, 2026
SCAN Strive (HMO C-SNP)SCAN Health PlanListedOct 3, 2026
DualConnect (HMO D-SNP)Santa Clara Family Health PlanListedSep 1, 2026

California Medical Board record

Licence A152670 · Current

Licensed to practise in California · since 2017 · expires 2027-04-30 · University of Utah School of Medicine.

No disciplinary actions, convictions, malpractice judgments or citations in this record.

Hospitals they work in

2 hospitals

These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.

  • Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend it
    Overall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
  • Stanford Health Care Tri-ValleyPleasanton, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Stanford Health Care, which runs 3 hospitalsPatients rate it 3 of 5 · 74% would definitely recommend it
    Overall rating: 5 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.178, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.237, Oct 2024 – Sep 2025
See every measure and the patient survey for Stanford Health Care

Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.

Every scored measure at Stanford Health Care
Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths5.31 (4.24 to 6.37) · 8,661 casesWorseJul 2022 – Jun 2024
Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits14.1 (12.7 to 15.7) · 2,191 casesWorseJan 2024 – Dec 2024
Postoperative respiratory failure rateComplications and deaths4.08 (1.95 to 6.21) · 5,296 casesBetterJul 2022 – Jun 2024
Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections0.317BetterOct 2024 – Sep 2025
Clostridium Difficile (C.Diff)Infections0.446BetterOct 2024 – Sep 2025
SSI - Colon SurgeryInfections0.241BetterOct 2024 – Sep 2025
Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits0.7 (0.6 to 0.9) · 3,348 casesBetterJan 2024 – Dec 2024
Abdominopelvic accidental puncture or laceration rateComplications and deaths1.06 (0.45 to 1.67) · 5,374 casesNo differentJul 2022 – Jun 2024
CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths0.86 (0.72 to 1)No differentJul 2022 – Jun 2024
Death rate among surgical inpatients with serious treatable complicationsComplications and deaths166.09 (137.88 to 194.3) · 470 casesNo differentJul 2022 – Jun 2024
Death rate for CABG surgery patientsComplications and deaths1.1 · 192 casesNoneJul 2022 – Jun 2025
Death rate for COPD patientsComplications and deaths6.4 · 146 casesNoneJul 2022 – Jun 2025
Death rate for heart attack patientsComplications and deaths9.7 · 253 casesNoneJul 2022 – Jun 2025
Death rate for heart failure patientsComplications and deaths6.3 · 880 casesNoneJul 2022 – Jun 2025
Death rate for pneumonia patientsComplications and deaths10.3 · 935 casesNoneJul 2022 – Jun 2025
Death rate for stroke patientsComplications and deaths8.7 · 501 casesNoneJul 2023 – Jun 2025
Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths2.1 · 7,730 casesNoneJul 2024 – Jun 2025
Iatrogenic pneumothorax rateComplications and deaths0.13 (0 to 0.27) · 20,799 casesNo differentJul 2022 – Jun 2024
In-hospital fall-associated fracture rateComplications and deaths0.28 (0.14 to 0.43) · 23,182 casesNo differentJul 2022 – Jun 2024
Postoperative acute kidney injury requiring dialysis rateComplications and deaths0.94 (0.2 to 1.68) · 5,694 casesNo differentJul 2022 – Jun 2024
Postoperative hemorrhage or hematoma rateComplications and deaths2.36 (1.54 to 3.19) · 7,846 casesNo differentJul 2022 – Jun 2024
Postoperative sepsis rateComplications and deaths5.2 (3.76 to 6.64) · 5,603 casesNo differentJul 2022 – Jun 2024
Postoperative wound dehiscence rateComplications and deaths1.38 (0.23 to 2.53) · 2,211 casesNo differentJul 2022 – Jun 2024
Pressure ulcer rateComplications and deaths0.52 (0.21 to 0.83) · 19,915 casesNo differentJul 2022 – Jun 2024
Rate of complications for hip/knee replacement patientsComplications and deaths3.6 · 416 casesNoneApr 2023 – Mar 2025
Central Line Associated Bloodstream Infection (ICU + select Wards)Infections0.869No differentOct 2024 – Sep 2025
MRSA BacteremiaInfections0.857No differentOct 2024 – Sep 2025
SSI - Abdominal HysterectomyInfections0.368No differentOct 2024 – Sep 2025
Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits16.2 · 247 casesNoneJul 2023 – Jun 2025
Heart failure (HF) 30-Day Readmission RateUnplanned return visits20.5 · 1,021 casesNoneJul 2023 – Jun 2025
Hospital return days for heart attack patientsUnplanned return visits47.8 · 258 casesNoneJul 2022 – Jun 2025
Hospital return days for heart failure patientsUnplanned return visits-1.6 · 990 casesNoneJul 2022 – Jun 2025
Hospital return days for pneumonia patientsUnplanned return visits20.8 · 976 casesNoneJul 2022 – Jun 2025
Pneumonia (PN) 30-Day Readmission RateUnplanned return visits16.5 · 959 casesNoneJul 2023 – Jun 2025
Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits5.2 (4.4 to 6.2) · 2,191 casesNo differentJan 2024 – Dec 2024
Rate of readmission after hip/knee replacementUnplanned return visits5.1 · 425 casesNoneJul 2023 – Jun 2025
Rate of readmission for CABGUnplanned return visits9.6 · 158 casesNoneJul 2023 – Jun 2025
Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits19.6 · 183 casesNoneJul 2023 – Jun 2025
Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits12.7 (10.4 to 15.4) · 4,578 casesNo differentJan 2022 – Dec 2024

What patients said (6,810 patients answered, 25% of those asked)

Patient survey stars by topic at Stanford Health Care
Cleanliness4
Nurse communication4
Doctor communication4
Communication about medicines3
Discharge information4
Overall hospital rating4
Quietness2
Recommend hospital5
Share of patients giving the best answer at Stanford Health Care
Room was "always" clean75%
Nurses "always" communicated well82%
Doctors "always" communicated well81%
Staff "always" explained63%
Yes, staff "did" give patients this information89%
Yes, staff "did" give patients information about help after discharge89%
Doctors "always" explained things so they could understand76%
Doctors "always" listened carefully80%
Doctors "always" treated them with courtesy and respect87%
Patients who gave a rating of "9" or "10" (high)79%
Staff "always" explained new medications76%
Nurses "always" explained things so they could understand77%
Nurses "always" listened carefully79%
Nurses "always" treated them with courtesy and respect88%
"Always" quiet at night53%
"YES", patients would definitely recommend the hospital83%
Staff "always" explained possible side effects50%
Yes, staff "did" give patients information about possible symptoms90%
See every measure and the patient survey for Stanford Health Care Tri-Valley

Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 2 better, 7 the same, 0 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.

Every scored measure at Stanford Health Care Tri-Valley
Central Line Associated Bloodstream Infection (ICU + select Wards)Infections0.178BetterOct 2024 – Sep 2025
Clostridium Difficile (C.Diff)Infections0.237BetterOct 2024 – Sep 2025
Abdominopelvic accidental puncture or laceration rateComplications and deaths0.79 (0 to 1.73) · 1,041 casesNo differentJul 2022 – Jun 2024
CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths0.79 (0.5 to 1.08)No differentJul 2022 – Jun 2024
Death rate among surgical inpatients with serious treatable complicationsComplications and deaths145.81 (96.5 to 195.12) · 72 casesNo differentJul 2022 – Jun 2024
Death rate for CABG surgery patientsComplications and deaths2.9 · 55 casesNoneJul 2022 – Jun 2025
Death rate for COPD patientsComplications and deaths8.6 · 92 casesNoneJul 2022 – Jun 2025
Death rate for heart attack patientsComplications and deaths12.5 · 96 casesNoneJul 2022 – Jun 2025
Death rate for heart failure patientsComplications and deaths9.5 · 395 casesNoneJul 2022 – Jun 2025
Death rate for pneumonia patientsComplications and deaths10.3 · 391 casesNoneJul 2022 – Jun 2025
Death rate for stroke patientsComplications and deaths10.1 · 162 casesNoneJul 2023 – Jun 2025
Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths3 · 1,736 casesNoneJul 2024 – Jun 2025
Iatrogenic pneumothorax rateComplications and deaths0.16 (0 to 0.37) · 4,425 casesNo differentJul 2022 – Jun 2024
In-hospital fall-associated fracture rateComplications and deaths0.22 (0.02 to 0.41) · 4,771 casesNo differentJul 2022 – Jun 2024
Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths3.45 (1.46 to 5.44) · 1,403 casesNo differentJul 2022 – Jun 2024
Postoperative acute kidney injury requiring dialysis rateComplications and deaths1.5 (0.05 to 2.94) · 645 casesNo differentJul 2022 – Jun 2024
Postoperative hemorrhage or hematoma rateComplications and deaths1.81 (0.38 to 3.24) · 1,279 casesNo differentJul 2022 – Jun 2024
Postoperative respiratory failure rateComplications and deaths8.53 (3.2 to 13.85) · 639 casesNo differentJul 2022 – Jun 2024
Postoperative sepsis rateComplications and deaths5.15 (1.89 to 8.41) · 648 casesNo differentJul 2022 – Jun 2024
Postoperative wound dehiscence rateComplications and deaths1.61 (0.14 to 3.07) · 370 casesNo differentJul 2022 – Jun 2024
Pressure ulcer rateComplications and deaths0.16 (0 to 0.83) · 4,160 casesNo differentJul 2022 – Jun 2024
Rate of complications for hip/knee replacement patientsComplications and deaths4 · 74 casesNoneApr 2023 – Mar 2025
Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections0.369No differentOct 2024 – Sep 2025
MRSA BacteremiaInfections1.112No differentOct 2024 – Sep 2025
SSI - Colon SurgeryInfections0No differentOct 2024 – Sep 2025
Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits13.1 · 110 casesNoneJul 2023 – Jun 2025
Heart failure (HF) 30-Day Readmission RateUnplanned return visits20.1 · 437 casesNoneJul 2023 – Jun 2025
Hospital return days for heart attack patientsUnplanned return visits-5.8 · 94 casesNoneJul 2022 – Jun 2025
Hospital return days for heart failure patientsUnplanned return visits-19.3 · 456 casesNoneJul 2022 – Jun 2025
Hospital return days for pneumonia patientsUnplanned return visits-0.3 · 402 casesNoneJul 2022 – Jun 2025
Pneumonia (PN) 30-Day Readmission RateUnplanned return visits15.8 · 358 casesNoneJul 2023 – Jun 2025
Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits6.8 (4.7 to 9.6) · 198 casesNo differentJan 2024 – Dec 2024
Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits10.1 (7.5 to 13.6) · 198 casesNo differentJan 2024 – Dec 2024
Rate of readmission after hip/knee replacementUnplanned return visits5.3 · 80 casesNoneJul 2023 – Jun 2025
Rate of readmission for CABGUnplanned return visits10.9 · 46 casesNoneJul 2023 – Jun 2025
Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits19.3 · 92 casesNoneJul 2023 – Jun 2025
Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits12.4 (9.6 to 16.2) · 1,532 casesNo differentJan 2022 – Dec 2024
Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits1 (0.8 to 1.2) · 929 casesNo differentJan 2024 – Dec 2024

What patients said (1,268 patients answered, 26% of those asked)

Patient survey stars by topic at Stanford Health Care Tri-Valley
Cleanliness3
Nurse communication3
Doctor communication4
Communication about medicines3
Discharge information4
Overall hospital rating3
Quietness2
Recommend hospital4
Share of patients giving the best answer at Stanford Health Care Tri-Valley
Room was "always" clean65%
Nurses "always" communicated well77%
Doctors "always" communicated well79%
Staff "always" explained58%
Yes, staff "did" give patients this information88%
Yes, staff "did" give patients information about help after discharge88%
Doctors "always" explained things so they could understand74%
Doctors "always" listened carefully78%
Doctors "always" treated them with courtesy and respect86%
Patients who gave a rating of "9" or "10" (high)70%
Staff "always" explained new medications72%
Nurses "always" explained things so they could understand73%
Nurses "always" listened carefully74%
Nurses "always" treated them with courtesy and respect84%
"Always" quiet at night42%
"YES", patients would definitely recommend the hospital74%
Staff "always" explained possible side effects44%
Yes, staff "did" give patients information about possible symptoms89%

Original Medicare doctor bills

$64,059

Medicare paid this office $64,059 for 262 people.

This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.

Largest Original Medicare bills
Vemp testing of upper and lower branches of inner ear nerve with interpretation and report142$18,172$128
Long return visit (40+ min)85$13,436$144
Evaluation and testing for balance with recording143$9,889$69
New patient visit (60+ min)56$9,475$169
Return visit (30+ min)30$3,503$109
See all 9 services
Every Original Medicare service billed
Vemp testing of upper and lower branches of inner ear nerve with interpretation and report142$18,172$128
Long return visit (40+ min)85$13,436$144
Evaluation and testing for balance with recording143$9,889$69
New patient visit (60+ min)56$9,475$169
Return visit (30+ min)30$3,503$109
Short return visit (20+ min)33$2,676$76
Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or41$1,421$28
Test to assess balance during warm and cool irrigation in both ears47$1,327$28
Test to assess balance during warm or cool irrigation in both ears34$515$15

Who their Medicare patients are

262 Original Medicare patients in 2024. Average age 73 · Under 65 8% · 85 and older 8% · Women 62% · Also on Medicaid 12% · Health risk score 1.05. At or below the middle of the specialty; the typical neurology clinician is at 1.61.

Conditions among them: High blood pressure 68% · Coronary heart disease 30% · Diabetes 24% · Depression 24% · Stroke 21% · Cancer 19% · Atrial fibrillation 16% · Chronic kidney disease 15% · Heart failure 12% · COPD 11% · Dementia 5%.

The office billed $659,331, Medicare allowed $82,019 and paid $64,059; for 673 services of 16 kinds.

Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.

Year by year

Original Medicare by year
2024262673731.05$659,331$64,059
2023250633731.19$545,472$60,298
2022251556721.07$543,761$44,970
2021242683711.10$583,366$59,598
2020218447721.10$250,475$37,846
2019233483721.17$69,708$40,111
2018181445721.17$63,565$39,708
201761598711.22$63,890$18,041
201632267701.09$28,530$8,148

Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.

See the services billed each year

2023: 9 services

Original Medicare services billed in 2023
Vemp testing of upper and lower branches of inner ear nerve with interpretation and report109$14,790$136
Long return visit (40+ min)93$14,490$128
New patient visit (60+ min)78$12,991$167
Evaluation and testing for balance with recording116$8,213$71
Return visit (30+ min)40$3,366$78
Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or49$1,624$28
Short return visit (20+ min)19$1,037$49
Test to assess balance during warm and cool irrigation in both ears32$856$27
Test to assess balance during warm or cool irrigation in both ears30$456$15

2022: 9 services

Original Medicare services billed in 2022
Long return visit (40+ min)109$13,381$119
New patient visit (60+ min)80$12,220$153
Evaluation and testing for balance with recording112$7,733$68
Return visit (30+ min)38$3,861$86
Vemp testing of upper and lower branches of inner ear nerve with interpretation and report24$2,583$108
Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or58$1,700$27
Short return visit (20+ min)17$1,151$58
Test to assess balance during warm and cool irrigation in both ears34$903$27
Test to assess balance during warm or cool irrigation in both ears53$767$14

2021: 9 services

Original Medicare services billed in 2021
Long return visit (40+ min)114$15,941$130
Vemp testing of upper and lower branches of inner ear nerve with interpretation and report114$13,569$119
New patient visit (60+ min)65$10,535$162
Evaluation and testing for balance with recording136$10,155$75
Return visit (30+ min)27$2,777$79
Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or61$2,068$30
Test to assess balance during warm and cool irrigation in both ears55$1,648$30
Short return visit (20+ min)13$864$51
Test to assess balance during warm or cool irrigation in both ears56$860$15

2020: 8 services

Original Medicare services billed in 2020
Long return visit (40+ min)109$11,280$99
Placement of scalp electrodes for assessment and recording of responses from several areas of the nerve-brain hearing system84$9,760$116
Evaluation and testing for balance with recording81$5,687$70
New patient visit (60+ min)36$5,315$148
Return visit (30+ min)26$2,015$69
Test to assess balance during warm and cool irrigation in both ears36$926$26
Short return visit (20+ min)18$764$38
Test to assess balance during warm or cool irrigation in both ears24$344$14

2019: 8 services

Original Medicare services billed in 2019
Long return visit (40+ min)100$11,278$99
Evaluation and testing for balance with recording140$9,910$70
New patient visit (60+ min)63$9,436$150
Return visit (30+ min)55$4,606$64
New patient visit (60+ min)11$1,459$133
Test to assess balance during warm and cool irrigation in both ears27$768$28
Evaluation and testing for balance with recording15$744$50
Test to assess balance during warm or cool irrigation in both ears18$268$15

2018: 5 services

Original Medicare services billed in 2018
Evaluation and testing for balance with recording143$11,009$72
Long return visit (40+ min)88$10,722$98
New patient visit (60+ min)68$10,235$151
Return visit (30+ min)39$4,097$71
Short return visit (20+ min)11$599$46

2017: 5 services

Original Medicare services billed in 2017
Evaluation and testing for balance with recording33$3,250$76
New patient visit (60+ min)25$3,135$125
Long return visit (40+ min)19$3,057$109
Return visit (30+ min)22$2,291$74
Short return visit (20+ min)17$1,317$53

2016: 2 services

Original Medicare services billed in 2016
New patient visit (60+ min)20$3,247$162
Evaluation and testing for balance with recording12$1,045$80

Drugs they prescribed that Part D paid

$53,112

Pharmacies billed $53,112 in 2024.

This is pharmacy cost, not the office bill, and not what patients paid.

Opioids were 0% of their Part D prescriptions (0 of 249) in 2024. At or below the middle of the specialty; the typical neurology clinician is at 0%.

197 generic and 52 brand-name prescriptions · $53,112 in drug cost.

Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.

Largest Part D drug costs
EmgalityMigraine30$30,375$1,013
AjovyNone11$7,745$704
NortriptylineNone32$1,145$36
AcetazolamideNone12$636$53
RizatriptanNone20$424$21
See all 8 drugs
Every Part D drug this clinician prescribed
EmgalityMigraine30$30,375$1,013
AjovyNone11$7,745$704
NortriptylineNone32$1,145$36
AcetazolamideNone12$636$53
RizatriptanNone20$424$21
EscitalopramNone18$284$16
TopiramateNone14$102$7
SertralineNone15$57$4

Year by year

Part D prescribing by year
2024249850% (0)21%$53,112
2023211890% (0)14%$30,590
2022192720% (0)7%$17,392
2021111500% (0)None$9,949
202069300% (0)0%$1,533
2019185630% (0)0%$3,158
2018174610% (0)None$4,413
2017235510% (0)20%$27,459
2016117380% (0)9%$6,448
201511138None10%$4,506
201491260% (0)None$5,522
20135328NoneNone$7,050

Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.

See the drugs prescribed each year

2023: 7 drugs

Part D drugs prescribed in 2023
EmgalityMigraine12$11,926$994
NortriptylineNone39$1,608$41
AcetazolamideNone11$793$72
RizatriptanNone11$420$38
TopiramateNone20$349$17
EscitalopramNone12$240$20
SertralineNone19$233$12

2022: 6 drugs

Part D drugs prescribed in 2022
Rizatriptan11$1,304$119
Nortriptyline35$1,156$33
Acetazolamide14$597$43
Escitalopram15$471$31
Sertraline34$414$12
Topiramate11$64$6

2021: 2 drugs

Part D drugs prescribed in 2021
Sertraline27$243$9
Escitalopram12$224$19

2019: 5 drugs

Part D drugs prescribed in 2019
Nortriptyline30$584$19
Escitalopram17$316$19
Sertraline11$145$13
Hydrochlorothiazide14$62$4
Diazepam15$50$3

2018: 6 drugs

Part D drugs prescribed in 2018
Nortriptyline25$377$15
Escitalopram13$141$11
Sertraline12$86$7
Hydrochlorothiazide24$78$3
Prochlorperazine Maleate11$60$5
Diazepam14$42$3

2017: 7 drugs

Part D drugs prescribed in 2017
Lyrica20$14,115$706
Verapamil Sr18$1,889$105
Venlafaxine20$1,247$62
Nortriptyline37$506$14
Topiramate19$246$13
Sumatriptan11$154$14
Diazepam15$80$5

2015: 2 drugs

Part D drugs prescribed in 2015
Levetiracetam22$501$23
Clopidogrel11$166$15

2014: 2 drugs

Part D drugs prescribed in 2014
Carbidopa-Levodopa Er14$1,276$91
Pravastatin11$230$21

Professional record

NPI
1750646857
Licence
AZ 47517, CA A152670California A152670: Current · expires 2027-04-30
Trained
University of Utah School of Medicine, 2012
Video visits
Lists video visits
Gender
Female
More record details
Sole proprietor
No
Taxonomy
Federal specialty code 207YX0901X (207YX0901X); Neurology (2084N0400X)
Mailing address
801 Welch Rd, Palo Alto, CA, 94304
NPI first listed
2012-07-05
NPI last updated
2024-04-29
NPI record certified
2024-04-29

This is when the NPI record was last certified, not a medical board exam.

Extra NPI addresses: 801 Welch Rd, Palo Alto, CA, 94304 · 240 W Thomas Rd, Phoenix, AZ, 85013